Dr. Shishir Seth is a leading Bone Marrow Transplant specialists and Hemato-oncologist in India.
In his rich experience of 14 years as a clinical hematologist, he has performed more than 150 Hematopoietic stem cell Transplants (BMT) successfully in his professional career. Many of these have been allogeneic stem cell transplants including Haplo-identical and antigen mismatch transplants.
Dr. Shishir is credited for performing more than 300 induction therapies for Acute leukemia only.
He holds a special interest in treatment of blood cancers, such as Acute Leukemia (AML/ ALL), Lymphoma, Multiple Myeloma, Chronic Myelo-proliferative Neoplasm, as well as blood and bone marrow disorders, such as Myelodysplastic syndrome, anemia, Thalassemia, bleeding and clotting disease.
Dr. Shishir has worked at several top-tier hospitals in Delhi and is considered one of the best BMT specialists in Delhi-NCR region. He has obtained his medical education and training from renowned institutions of the nation and abroad, including a fellowship in Bone Marrow Transplantation from the Vancouver General Hospital, Canada.
He has published and presented many research papers in the field of hemato-oncology and stem cell transplantation in reputed national and international medical journals.
Education & Training
MBBS from Lala Lajpat Rai Memorial Medical College, Meerut
MD – Pathology from Seth G S Medical College & King Edward Memorial Hospital, Mumbai
DM - Clinical Hematology from Seth G S Medical College and King Edward Memorial Hospital, Mumbai
Fellow - Leukemia/Bone Marrow Transplantation at Division of Hematology, Vancouver General Hospital, British Columbia Cancer Agency, Canada
Consultant - Hemato-oncology & Stem Cell Transplant (BMT) at Rajiv Gandhi Cancer Institute, New-Delhi
Senior resident (DM - Clinical Hematology) at Seth G.S. Medical College & King Edward Memorial (KEM)Hospital, Mumbai-India
Consultant at Moolchand Hospital, New Delhi
Resident at GTB Hospital, New Delhi
Clinical assistant- Hematology at PD Hinduja National Hospital, Mumbai
AMO at Bombay Hospital, Mumbai
Junior resident at Seth G.S. Medical College & KEM hospital, Mumbai-India
Principal Investigator for 2010DRL001: An investigator initiated observational study to evaluate the response rate and toxicity (safety) of the combination of bendamustine and rituximab (BR) in fresh adult chronic lymphocytic leukemia patients
Principal Investigator for IVPL_RT_01: A study of Rituximab in patients with Non Hodgkins Lymphoma a type of cancer.
Acute Leukemia (AML/ ALL)
Chronic myeloid leukemia (CML)
Chronic lymphoblastic leukemia (CLL)
Chronic Myelo-proliferative Neoplasm
Aplastic Anemia, Sickle cell anemia
Bleeding and clotting disorders
Research and Publications
An unusual presentation of pediatric acute lymphoblastic leukemia. Indian J Hematol Blood Transfus, 2008:24(2) 59-62
“Lymph node and Tuberculosis: Clinical, Pathological and Microbiological Correlation.” In CYTOCON-2003 at Pune, India.
“Spectrum of small intestinal lymphoma in western India” in International conference on emerging trends in hematology and immunohematology at Mumbai, India.
“Chronic Myeloid Leukemia: Demographic and clinical profile from a tertiary center in western India” in Leukemias: molecular insights to treatment paradigms at Mumbai.
Hematopoietic Cell Transplantation in Lymphoma: Why & When; Evidence Based Review. Cancer News, Dec 2011;5(5) 10-12.
Acute Myeloid Leukemia- An Update. RGCI Newsletter-External- Mar 2012; 16(3) 2-3.
Autologous Stem Cell Transplantation in a patient with Burkitts Lymphoma and paraparesis. Rajeeb Kumar Deo; Prakash Chitalkar; Shishir Seth,; Kundan Chufal, Hilal Ahmed Yattoo, Abha Bhalla - Poster presented at the 52nd Annual Meeting of the Indian Society of Hematology and Transfusion Medicine, Chandigarh, November 11-13, 2011.
Life Member - Indian Society of Hematology and Transfusion Medicine
Disclaimer: Lyfboat does not provide professional medical opinion on the treatment or diagnosis of a particular ailment. All the offered services and information presented on www.lyfboat.com are only for the purpose of public knowledge and cannot substitute the professional consultation of the physician. Lyfboat strongly advice against copying or cloning of its web content and follows the legal protocols for protection of its intellectual property.